Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

56.050
+2.5504.77%
Volume:43.68M
Turnover:2.43B
Market Cap:230.70B
PE:41.35
High:56.500
Open:53.500
Low:53.250
Close:53.500
52wk High:56.500
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:2.19
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.356
ROE:11.38%
ROA:7.60%
PB:4.11
PE(LYR):41.35
PS:8.36

Loading ...

WUXI BIO Executes Major Share Buyback, Spending Nearly HK$100 Million

Stock News
·
Jun 18

WuXi Biologics Adds 0.16 Million New Shares from Option Exercises, While Repurchasing 3.26 Million Shares for HKD 99.74 Million

Bulletin Express
·
Jun 18

WuXi Biologics files HKEX next-day disclosure return, issues 155,000 new shares via option exercises

Reuters
·
Jun 18

Wuxi Biologics (Cayman) Stock Climbs 3.2% in Hong Kong

Dow Jones
·
Jun 18

WuXi Biologics Suzhou biosafety testing center wins fourth EMA GMP certificate

Reuters
·
Jun 18

Movement Alert|WuXi Biologics Rises 3.35% in Regular Trading, Pharma Sector Buyback Wave Boosts Market Confidence

Market Focus
·
Jun 18

CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical

MT Newswires Live
·
Jun 17

WuXi XDC unit BioDlink wins RMB 19 million process development, manufacturing order from WuXi Biologics

Reuters
·
Jun 17

CANbridge signs WuXi Biologics CRDMO services framework agreement with RMB 39.8 million 2026 cap

Reuters
·
Jun 16

Wuxi Biologics (Cayman) Stock Falls 2.9% in Hong Kong

Dow Jones
·
Jun 16

Movement Alert|WuXi Biologics Falls 3.04% in Regular Trading, Weighed by Geopolitical Headwinds After Affiliate Listed on US Defense Blacklist

Market Focus
·
Jun 16

WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide

Simply Wall St.
·
Jun 13

WUXI BIO Executes HK$99.8 Million Share Buyback on June 12

Stock News
·
Jun 12

WuXi Biologics files HKEX next-day return, share capital rises by 21,000 shares

Reuters
·
Jun 12

Wuxi Biologics (Cayman) Stock Climbs 3.8% in Hong Kong

Dow Jones
·
Jun 12

Movement Alert|WuXi Biologics Rises 3.21% in Regular Trading, Aggressive Buyback Program and Sector Rebound Drive Recovery

Market Focus
·
Jun 12

WuXi Biologics makes S&P Global Sustainability Yearbook China edition for fourth straight year

Reuters
·
Jun 11

WUXI BIO issues 1.48 million new shares on option exercise and buys back 3.39 million shares under new mandate

Bulletin Express
·
Jun 11

WUXI BIO Executes Share Buyback, Spending Nearly HK$100 Million on June 11th

Stock News
·
Jun 11

Movement Alert|WuXi Biologics Falls 4.21% in Regular Trading, Continued Pressure from US Regulatory Actions Against WuXi Group

Market Focus
·
Jun 10